Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey

Article Biochemistry & Molecular Biology

A global survey of potential acceptance of a COVID-19 vaccine

Jeffrey V. Lazarus et al.

Summary: Survey data from 19 countries reveals varying attitudes towards acceptance of a COVID-19 vaccine, with trust in government being linked to vaccine confidence.

NATURE MEDICINE (2021)

Add to Collection

Letter Gastroenterology & Hepatology

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients Reply

Gil Melmed et al.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Corey A. Siegel et al.

GUT (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Editorial Material Gastroenterology & Hepatology

SARS-CoV-2 vaccination in IBD: more pros than cons

Ferdinando D'Amico et al.

Summary: With the rollout of COVID-19 vaccines, there is limited evidence on their efficacy and safety for immunocompromised individuals, including those with inflammatory bowel diseases. Drawing from experiences with other vaccines or immune-mediated inflammatory disorders can help address questions on the advantages and disadvantages of vaccination.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Letter Gastroenterology & Hepatology